TPIV200 stimulates T cells to attack ovarian and triple-negative breast tumor cells that over-express the folate receptor alpha protein.
By John Schieszer
Advertisement
Articles by By John Schieszer
Advertisement
Latest Updated Articles
- Multi-epitope T-cell Vaccine Shows Promise in Ovarian, Breast Cancer
Published: May 16th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC
2
Lifileucel Confers Durable Responses in Pretreated Advanced NSCLC Type
3
EDIC Displays Continuous Evolution as Variable in EOT Grade 3 Lymphopenia
4
How Can Oncology Staffing Shortages Be Remedied?
5
